Found: 11
Select item for more details and to access through your institution.
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 2, p. 275, doi. 10.1007/s40257-020-00510-6
- By:
- Publication type:
- Article
Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 5, p. 711, doi. 10.1007/s40257-019-00450-w
- By:
- Publication type:
- Article
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
- Published in:
- BMC Dermatology, 2016, v. 16, p. 1, doi. 10.1186/s12895-016-0051-4
- By:
- Publication type:
- Article
Tolerability of Topical Treatments for Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 1, p. 71, doi. 10.1007/s13555-019-0280-7
- By:
- Publication type:
- Article
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years.
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 2, p. 175, doi. 10.1007/s40272-021-00490-y
- By:
- Publication type:
- Article
Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area.
- Published in:
- Acta Dermato-Venereologica, 2020, v. 100, n. 6, p. 1, doi. 10.2340/00015555-3489
- By:
- Publication type:
- Article
Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation Analysis.
- Published in:
- Acta Dermato-Venereologica, 2019, v. 99, n. 9, p. 756, doi. 10.2340/00015555-3181
- By:
- Publication type:
- Article
Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 1, p. 25, doi. 10.1111/1346-8138.15123
- By:
- Publication type:
- Article
Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 10, p. 1344, doi. 10.1002/jcph.1624
- By:
- Publication type:
- Article
Systemic Tofacitinib Concentrations in Adult Patients With Atopic Dermatitis Treated With 2% Tofacitinib Ointment and Application to Pediatric Study Planning.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 6, p. 811, doi. 10.1002/jcph.1360
- By:
- Publication type:
- Article
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 2, p. 567, doi. 10.1007/s40744-018-0131-5
- By:
- Publication type:
- Article